This program addresses the massive problem of iatrogenic injury and death, the inadequacy of the law’s conventional response, and several of the more innovative approaches the law might be taking in the future to raise the level of patient safety. Those more innovative approaches will be more regulatory than litigative.
Three areas to be discussed are new incentives for investment in safety, error reporting, and engaged surveillance.
Learning Objectives:
• Acquire a more complete picture of the nature and extent of the problem of iatrogenic harm.
• Understand the limited efficacy of malpractice liability in encouraging prevention of harm.
• Learn about new incentives (existing and proposed) to create a business case for patient safety.
• Learn about failings of error reporting regimes.
• Learn about engaged surveillance.
MODERATED-Session 5 of 10 - Mr. Kornblum, a highly experienced trial and litigation lawyer for over ...
MODERATED-Session 9 of 10 - Mr. Kornblum, a highly experienced trial and litigation lawyer for over ...
We are at that time again. Resolution time. Or maybe they’re already nothing more than another...
MODERATED-This CLE will cover the critical ethics issues involving multijurisdictional practice and ...
MODERATED-Session 7 of 10 - Mr. Kornblum, a highly experienced trial and litigation lawyer for over ...
Bias and discrimination continue to shape workplace dynamics, legal practice, and professional respo...
MODERATED-Part 2 of 2 - In this presentation, I will discuss strategies for cross-examining expert w...
This Continuing Legal Education presentation covers electronic discovery and the related ethical dut...
MODERATED-Session 8 of 10 -Mr. Kornblum, a highly experienced trial and litigation lawyer for over 5...
A litigator’s role is to shape how key decision-makers - judges, jurors, and opposing counsel ...